2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow MDD: new trials by email Literature Review of MDD trials Research Report on MDD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment Brexpiprazole - MDD | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 48 | 2013-11-01 | 2016-03-29 |
| A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder TC-5214, Placebo - Major Depressive Disorder, MDD | Phase 3 | Completed | AstraZeneca | 813 | 2010-06-01 | 2014-04-11 |
Depressive Disorder, Major (2) · Anxiety Disorders (1) · Depression (1) · Mental Disorders (1) · Psychotic Disorders (1) · Schizophrenia (1)
Depressive Disorder (2) · Mood Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Mental Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
brexpiprazole (1)
AstraZeneca (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (2) · Puerto Rico (1)
Andrew . J Cutler, MD (1) · Hans A. Eriksson, MD, Ph.D, MBA (1) · Junichi Hashimoto, PhD (1)